Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04596592 · ClinicalTrials.gov registry record

Pubertal Blockade and Estradiol Effects on Cardiometabolic Health for Transitioning Youth

A clinical trial of Insulin Sensitivity and Gender Dysphoria, sponsored by University of Colorado, Denver.

Recruiting
Registry status
90
Enrollment target
1
Study location

NCT04596592 is a study of Insulin Sensitivity and Gender Dysphoria that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 90 participants, above the 70-participant average among 29 other Insulin Sensitivity trials with a reported enrollment target (29% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04596592, a study of Insulin Sensitivity and Gender Dysphoria, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
90 participants
Enrollment target
1
Study location

Study Summary

To evaluate the effect of estradiol with or without a prior gonadotropin releasing hormone analogue on insulin sensitivity and vascular function in transgender females compared to cisgender controls.

Study Locations (1)

Colorado

  • Children's Hospital Colorado - Aurora

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2021-02-15
Est. Completion 2026-07-31

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT04596592

The ClinicalTrials.gov registry entry for NCT04596592 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 70-participant average among 29 other Insulin Sensitivity trials with a reported enrollment target (29% higher). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Insulin Sensitivity appearing as the primary indexed condition, and to 0 interventions.

NCT04596592 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT04596592 about?

NCT04596592 is a clinical study titled "Pubertal Blockade and Estradiol Effects on Cardiometabolic Health for Transitioning Youth". To evaluate the effect of estradiol with or without a prior gonadotropin releasing hormone analogue on insulin sensitivity and vascular function in transgender females compared to cisgender controls.

What is the current status of trial NCT04596592?

This trial is currently recruiting. The enrollment target is 90 participants. The study started on 2021-02-15. Estimated completion is 2026-07-31.

What conditions does trial NCT04596592 study?

This clinical trial studies the following conditions: Insulin Sensitivity, Gender Dysphoria, Transgenderism.

Who is sponsoring clinical trial NCT04596592?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04596592 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insulin Sensitivity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.